Further Conversion Limitation. Notwithstanding anything contained herein to the contrary, the Holder shall not be entitled to convert pursuant to the terms of this Note any amounts that would be convertible into Conversion Shares prior to the earlier to occur of (i) two hundred seventy (270) days after the date hereof and (i) one hundred eighty (180) days after the date of the initial public offering of Common Stock. The Conversion Shares limitation described in this Section 2.8 shall automatically become null and void without any notice to any Company upon the occurrence and during the continuance of an Event of Default.
Appears in 3 contracts
Samples: Secured Revolving Note (Accentia Biopharmaceuticals Inc), Secured Convertible Minimum Borrowing Note (Accentia Biopharmaceuticals Inc), Secured Convertible Minimum Borrowing Note (Accentia Biopharmaceuticals Inc)
Further Conversion Limitation. Notwithstanding anything contained herein to the contrary, the Holder shall not be entitled to convert pursuant to the terms of this Note to convert any amounts that would be convertible into Conversion Shares prior to the earlier to occur of (i) two hundred seventy (270) days after the date hereof and (i) one hundred eighty (180) days after the date of the initial public offering of Common Stock. The Conversion Shares limitation described in this Section 2.8 3.10 shall automatically become null and void without any notice to any Company upon the occurrence and during the continuance of an Event of Default.
Appears in 3 contracts
Samples: Secured Convertible Term Note (Accentia Biopharmaceuticals Inc), Secured Convertible Term Note (Accentia Biopharmaceuticals Inc), Secured Convertible Term Note (Accentia Biopharmaceuticals Inc)
Further Conversion Limitation. Notwithstanding anything contained herein to the contrary, the Holder shall not be entitled to convert pursuant to the terms of this Note any amounts that would be convertible into Conversion Shares prior to the earlier to occur of (i) two hundred seventy (270) days after the date hereof and (i) one hundred eighty (180) days after the date of the initial public offering of Common Stock. The Conversion Shares limitation described in this Section 2.8 3.10 shall automatically become null and void without any notice to any Company upon the occurrence and during the continuance of an Event of Default.
Appears in 2 contracts
Samples: Secured Convertible Minimum Borrowing Note (Accentia Biopharmaceuticals Inc), Secured Convertible Minimum Borrowing Note (Accentia Biopharmaceuticals Inc)